Inotiv offers advanced hepatic research services and models to expedite drug development by providing high-quality data for informed decision-making.
At Inotiv, we understand the critical role the liver plays in drug metabolism and toxicity assessment. By leveraging our extensive expertise and state-of-the-art technologies, we provide a wide range of hepatic research services and models designed to accelerate drug discovery and development pipelines to enhance decision-making processes.
Our comprehensive suite of hepatic research models and services includes hepatocyte isolation and characterization, in vitro hepatic metabolism studies, hepatotoxicity screening, and specialized assays to evaluate drug-induced liver injury. With a focus on delivering high-quality data and actionable insights, we empower our clients to make informed decisions at every stage of the drug discovery and development process. Partner with Inotiv and gain access to unrivaled scientific expertise, innovative methodologies, and personalized support to drive your research forward.
What specific aspect of hepatic disease are you interested in studying? What do you think you might find?
This could involve cell cultures, animal models, or human studies depending on the research question.
Once you have your model, you’ll perform experiments to test your hypothesis. This may involve exposing cells or animals to a potential causative agent or treatment and measuring various markers of liver health.
After your experiments are complete, you’ll need to analyze the data you collected. This may involve statistical analysis to see if your results are significant.
Based on your analysis, you’ll draw conclusions about your hypothesis and write up your findings for publication in a scientific journal or presentation at a conference.
in Preclinical Drug Development
Watch Webinar Watch Webinar
Copyright © 2024 Inotiv. All Rights Reserved.